Julie BRAULT

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (18)

• Lentivector cryptic splicing mediates increase in CD34+ clones expressing truncated HMGA2 in human X-linked severe combined immunodeficiency
  Nature Communications 2022 DOI: 10.1038/s41467-022-31344-x
  +Save
• CRISPR-targeted MAGT1 insertion restores XMEN patient hematopoietic stem cells and lymphocytes
  Blood 2021 DOI: 10.1182/blood.2021011192
  +Save
• Correction of X-CGD patient HSPCs by targeted CYBB cDNA insertion using CRISPR/Cas9 with 53BP1 inhibition for enhanced homology-directed repair
  Colin L. Sweeney, Mara Pavel-Dinu, Uimook Choi +13 more
  Gene Therapy 2021 DOI: 10.1038/s41434-021-00251-z
  +Save
• Enhanced homology-directed repair for highly efficient gene editing in hematopoietic stem/progenitor cells
  Suk See De Ravin, Julie Brault, Ronald J. Meis +20 more
  Blood 2021 DOI: 10.1182/blood.2020008503
  +Save
• NADPH oxidase correction by mRNA transfection of apheresis granulocytes in chronic granulomatous disease
  Blood Advances 2020 DOI: 10.1182/bloodadvances.2020003224
  +Save
• Clinical, functional and genetic characterization of Sixteen Patients Suffering from Chronic Granulomatous Disease variants - Identification of Twelve Novel Mutations in CYBB
  2020 DOI: 10.22541/au.159361967.70134008
  +Save
• Clinical, functional and genetic characterization of 16 patients suffering from chronic granulomatous disease variants – identification of 11 novel mutations in CYBB
  Clinical and Experimental Immunology 2020 DOI: 10.1111/cei.13520
  +Save
• MAGT1 messenger RNA-corrected autologous T and natural killer cells for potential cell therapy in X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia disease
  Cytotherapy 2020 DOI: 10.1016/j.jcyt.2020.08.013
  +Save
• NOX4 is the main NADPH oxidase involved in the early stages of hematopoietic differentiation from human induced pluripotent stem cells
  Free Radical Biology and Medicine 2020 DOI: 10.1016/j.freeradbiomed.2019.10.005
  +Save
• Tumor microenvironment and clonal monocytes from chronic myelomonocytic leukemia induce a procoagulant climate
  Blood Advances 2019 DOI: 10.1182/bloodadvances.2018026955
  +Save
• CRISPR/Cas9 applications in gene therapy for primary immunodeficiency diseases
  Emerging Topics in Life Sciences 2019 DOI: 10.1042/ETLS20180157
  +Save
• Ex vivo models of chronic granulomatous disease
  Methods in Molecular Biology 2019 DOI: 10.1007/978-1-4939-9424-3_35
  +Save
• Therapeutic effects of proteoliposomes on X-linked chronic granulomatous disease: Proof of concept using macrophages differentiated from patient-specific induced pluripotent stem cells
  International Journal of Nanomedicine 2017 DOI: 10.2147/IJN.S128611
  +Save
• Nouveaux modèles d’étude de la Granulomatose Septique Chronique grâce aux cellules souches pluripotentes induites – Application au développement de la thérapie protéique
  2015 DOI: 10.70675/59905467z7e7dz449ez961cz0b66b9f83b9b
  +Save
• Genetic disorders coupled to ROS deficiency
  Redox Biology 2015 DOI: 10.1016/j.redox.2015.07.009
  +Save
• Differential impact of glucose levels and advanced glycation end-products on tubular cell viability and pro-inflammatory/profibrotic functions
  Biochemical and Biophysical Research Communications 2014 DOI: 10.1016/j.bbrc.2014.08.042
  +Save
• Optimized generation of functional neutrophils and macrophages from patient-specific induced pluripotent stem cells: Ex vivo models of X0-Linked, AR220- and AR470-chronic granulomatous diseases
  BioResearch Open Access 2014 DOI: 10.1089/biores.2014.0045
  +Save
• Study of microbiological safety of 25 oncology drugs after multiple uses in aseptic conditions
  International Journal of Pharmaceutical Compounding 2011
  +Save